Showing results (91-100 of 103) with videos related to

Sort By:
Pageof 11
Bioorganic & Medicinal Chemistry|January 10, 2021
Design, synthesis and anti-inflammatory activity of imidazol-5-yl pyridine derivatives as p38α/MAPK14 inhibitorEslam M H Ali, Mohammed S Abdel-Maksoud, Rasha Mohamed Hassan, et al.
Ebiomedicine|February 1, 2025
Comparison of autism domains across thirty rare variant genotypesNabila M H Ali, Samuel J R A Chawner, Leila Kushan-Wells, et al.
Osteoarthritis and Cartilage|June 29, 2015
Characterization of degenerative human facet joints and facet joint capsular tissuesJ-S Kim, M H Ali, F Wydra, et al.
Veterinary World|August 25, 2023
Circulating foot-and-mouth disease virus serotype A African-genotype IV in Egypt during 2022Momtaz A Shahein, Heba A Hussein, M H Ali, et al.
European Journal of Medicinal Chemistry|February 18, 2021
Design, synthesis, biological evaluation, and docking studies of novel (imidazol-5-yl)pyrimidine-based derivatives as dual BRAFV600E/p38α inhibitorsEslam M H Ali, Rania Farag A El-Telbany, Mohammed S Abdel-Maksoud, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|January 7, 2022
Structural optimization of 4-(imidazol-5-yl)pyridine derivatives affords broad-spectrum anticancer agents with selective B-RAFV600E/p38α kinase inhibitory activity: Synthesis, in vitro assays and in silico studyEslam M H Ali, Karim I Mersal, Usama M Ammar, et al.
The Veterinary Quarterly|December 22, 2025
Perfect diagnostic agreement between canine- and feline-specific parvovirus PoC antigen kits in feline panleukopeniaMahmoud S Safwat, Manar M Farouk, Ahmad Zaki Anwer, et al.
European Journal of Medicinal Chemistry|September 30, 2023
Evaluation of novel pyrazol-4-yl pyridine derivatives possessing arylsulfonamide tethers as c-Jun N-terminal kinase (JNK) inhibitors in leukemia cellsKarim I Mersal, Mohammed S Abdel-Maksoud, Eslam M H Ali, et al.
BMC Veterinary Research|October 4, 2025
Emergence, surge, and fading of the novel feline parvovirus Thr390Ala mutant in Egyptian cats during 2023: insights from a comprehensive full-length VP2 genetic analysisMahmoud S Safwat, Chen Xi, Samah El-Sayed M, et al.
Archiv Der Pharmazie|May 10, 2025
Structural Optimization and MD Simulation Study of Benzimidazole Derivatives as Potent Mutant FLT3 Kinase Inhibitors Targeting AMLNada Alaa El-Deen, RosaAnna DeFilippis, Amal Kamal Abdel-Aziz, et al.
Pageof 11